- Home
- PRAX vs CAL Comparison
PRAX vs CAL Comparison
Compare PRAX & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- CAL
- Stock Information
- Founded
- PRAX 2015
- CAL 1878
- Country
- PRAX United States
- CAL United States
- Employees
- PRAX N/A
- CAL N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- PRAX Health Care
- CAL Consumer Discretionary
- Exchange
- PRAX Nasdaq
- CAL Nasdaq
- Market Cap
- PRAX 599.7M
- CAL 520.3M
- IPO Year
- PRAX 2020
- CAL N/A
- Fundamental
- Price
- PRAX $46.32
- CAL $13.89
- Analyst Decision
- PRAX Strong Buy
- CAL Hold
- Analyst Count
- PRAX 11
- CAL 1
- Target Price
- PRAX $114.73
- CAL $14.00
- AVG Volume (30 Days)
- PRAX 299.7K
- CAL 1.0M
- Earning Date
- PRAX 08-12-2025
- CAL 05-29-2025
- Dividend Yield
- PRAX N/A
- CAL 2.03%
- EPS Growth
- PRAX N/A
- CAL N/A
- EPS
- PRAX N/A
- CAL 2.43
- Revenue
- PRAX $8,122,000.00
- CAL $2,677,706,000.00
- Revenue This Year
- PRAX N/A
- CAL N/A
- Revenue Next Year
- PRAX $6,358.50
- CAL $3.48
- P/E Ratio
- PRAX N/A
- CAL $5.68
- Revenue Growth
- PRAX 270.02
- CAL N/A
- 52 Week Low
- PRAX $26.70
- CAL $12.09
- 52 Week High
- PRAX $91.83
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- PRAX 63.87
- CAL 52.67
- Support Level
- PRAX $40.93
- CAL $12.14
- Resistance Level
- PRAX $44.40
- CAL $12.83
- Average True Range (ATR)
- PRAX 2.26
- CAL 0.69
- MACD
- PRAX -0.08
- CAL 0.16
- Stochastic Oscillator
- PRAX 95.12
- CAL 98.90
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.